Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome – a pilot study

References

• Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903–12.
   PubMed Web of Science ®Google Scholar
• Longstreth G, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller R. Functional bowel disorders In: Drossman DA, Corazziari E, Delvaux M, Talley NJ, Thompson WG, Whitehead WE, editors. Rome III: the functional gastrointestinal disoders. 1st ed. McLean VA: Degnon Associates; 2006. pp 487–555.
   Google Scholar
• Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662–71.
   PubMed Web of Science ®Google Scholar
• Chaudhary NA, Truelove SC. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962;31:307–22.
   PubMedGoogle Scholar
• Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578–83.
   PubMed Web of Science ®Google Scholar
• Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome -- a meta-analysis. Am J Gastroenterol 2006;101:1894–9; quiz 942.
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778–83.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804–11.
   PubMed Web of Science ®Google Scholar
• Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993;38:1590–5.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523–6.
   PubMed Web of Science ®Google Scholar
• Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913–20.
   PubMed Web of Science ®Google Scholar
• Desreumaux P, Ghosh S. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence. Aliment Pharmacol Ther 2006;24(Suppl 1):2–9.
   PubMed Web of Science ®Google Scholar
• Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med 2005;201:1205–15.
   PubMed Web of Science ®Google Scholar
• Barbara G, Cremon C, Pallotti F, De Giorgio R, Stanghellini V, Corinaldesi R. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 2009;48(Suppl 2):S95–7.
   Google Scholar
• Giardiello FM, Lazenby AJ, Bayless TM, Levine EJ, Bias WB, Ladenson PW, Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci 1989;34:1730–8.
   PubMedGoogle Scholar
• Mullhaupt B, Guller U, Anabitarte M, Guller R, Fried M. Lymphocytic colitis: clinical presentation and long term course. Gut 1998;43:629–33.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000;95:999–1007.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998;43:400–11.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976;128:280–9.
   PubMed Web of Science ®Google Scholar
• Kaiser J. An exact and a monte carlo proposal to the fisher-pitman permutation tests for paired replicates and for independent samples. Stata J 2007;7:402–12.
   Google Scholar
• Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill; 1988. pp 128–37.
   Google Scholar
• Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, De Giorgio R, Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther 2009;30:245–52.
   PubMed Web of Science ®Google Scholar
• Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007;42(Suppl 17):41–7.
   PubMedGoogle Scholar
• Dunlop SP, Jenkins D, Neal KR, Naesdal J, Borgaonker M, Collins SM, Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:77–84.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400–6.
   PubMed Web of Science ®Google Scholar
• Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR. Post-traveler's diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 2003;98:596–9.
   PubMedGoogle Scholar
• Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004;99:1774–8.
   PubMed Web of Science ®Google Scholar
• Tuteja AK, Talley NJ, Gelman SS, Alder SC, Thompson C, Tolman K, Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008;53:271–6.
   PubMedGoogle Scholar
• Tanaka M, Mazzoleni G, Riddell RH. Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut 1992;33:65–70.
   PubMed Web of Science ®Google Scholar
• Thijs WJ, van Baarlen J, Kleibeuker JH, Kolkman JJ. Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. Neth J Med 2005;63:137–40.
   PubMedGoogle Scholar
• Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 2000;51:318–26.
   PubMed Web of Science ®Google Scholar